CSE: CHX OTC: CHXIF Frankfurt: EIY2
ChroMedX CEO Lahav Gil Invited to Speak on Industry Panel at bioTEC, Biotechnology and Bioengineering Conference
March 27, 2018 – ChroMedX Corp. (the “Company”) (CSE: CHX, OTC: CHXIF, Frankfurt: EIY2), developer of the HemoPalm Handheld Blood Analyzer Platform, is pleased to announce that CEO Lahav Gil will speak at the 2018 bioTEC Conference at the University of Waterloo to discuss innovation culture and Medtech commercialization.
Lahav is an invited speaker on the industry panel at the bioTEC Biotech and Bioengineering Conference, the first of its kind in Canada. The conference is designed as a platform for students, researchers, professionals and entrepreneurs to connect and discuss advances in the biomedical field. Notable past speakers include Frank Baylis of Baylis Medical and Dr. Julie Audet of University of Toronto.
“I truly appreciate the opportunity to be invited to this event.” said Lahav Gil, CEO & Director of ChroMedX Corp. “It is so important to have students, graduates and academic leadership mixing and meeting with industry professionals and learning from one another.”
Lahav has lectured at the Bzelel Academy of Art and Design in Israel, and has appeared as a guest lecturer at several major universities in Toronto in the area of innovation culture, technology entrepreneurship, medical device commercialization and values based leadership.
This event will be held on November 17, 2018 on the University of Waterloo’s campus. More information is available on the conference’s website.
|